Guilherme Barbosa Pinto

Guilherme Barbosa Pinto

Auto-generated profile, based on publicly available information

Guilherme Barbosa Pinto

Discipline of Infectology, Centro Universitário FMABC, Santo André, SP, Brazil

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2026 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
GHGabriela Pizarro Ossa Ferro Henriques
Gabriela Pizarro Ossa Ferro Henriques
GPGuilherme Barbosa Pinto
Guilherme Barbosa Pinto
EIErika Yukie Ishigaki
Erika Yukie Ishigaki
NDNicoly Caroline de Andrade Delmondes
Nicoly Caroline de Andrade Delmondes
DNDaniel Ayabe Ninomiya
Daniel Ayabe Ninomiya
MMMarcello Magri
Marcello Magri
Tuberculosis (TB) remains a major public health concern globally and in Brazil. Although ambulatory treatment is recommended for most patients, hospitalizations still occur due to severe clinical presentations, social vulnerability, or treatment complications. We conducted a retrospective, observational study of TB-related hospitalizations at a regional referral tertiary public hospital in São Paulo, Brazil, from 2013 to 2022. Medical records were reviewed to collect epidemiological, clinical, laboratory, and microbiological data. Among 197 hospitalizations for TB, 73.1% were male, with a mean age of 41.8 years. TB-HIV coinfection was identified in 55.3% of cases, with 83.5% of these patients having CD4+ T-cell counts ≤ 200 cells/mm3. Malnutrition (40.1%), smoking (64.0%), alcohol use (51.6%), and illicit drug use (58.1%) were common. Pulmonary TB occurred in 48.7%, while 29.4% had extrapulmonary TB and 21.8% disseminated forms. Diagnostic confirmation was achieved in 74.1%, including bacilloscopy, culture, molecular test, ADA and biopsy. The main reason for hospitalization was diagnostic work-up (74.1%), with a median symptom duration of 3.6 months. ICU care was required in 23.8% of cases. In-hospital mortality was 17.3%, and significant risk factors included malnutrition and thrombocytopenia. In this high-burden setting, TB hospitalizations were associated with social vulnerability, HIV coinfection, and delayed diagnosis. The high frequency of severe presentations highlights the importance of early detection and access to molecular testing. Improved integration between outpatient care and hospital services may reduce the need for hospitalization and improve outcomes.

1 January 2026 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
RSRaquel Couto e Silva
Raquel Couto e Silva
DGDanilo Bortolotto Gurian
Danilo Bortolotto Gurian
GPGuilherme Barbosa Pinto
Guilherme Barbosa Pinto
MSMurilo Freua Sequeira
Murilo Freua Sequeira
EIErika Yukie Ishigaki
Erika Yukie Ishigaki
MMMarcello Magri
Marcello Magri
Infective endocarditis (IE) remains a life-threatening condition with high mortality, particularly in middle-income countries where access to advanced diagnostics and timely surgery is unequal. Real-world data from such settings remain limited. This study describes the clinical and microbiological characteristics of patients with suspected IE and identifies independent predictors of in-hospital mortality at a Brazilian tertiary referral center. We conducted a retrospective cohort including adults hospitalized with suspected IE between 2012 and 2022. Cases were classified according to modified Duke criteria. Demographic, clinical, laboratory, microbiological, and echocardiographic data were collected, and independent predictors of in-hospital mortality were identified using multivariable logistic regression. Of the 112 patients evaluated, 66 met the criteria for definite or possible IE. Median age was 55 years, 59.1% were male, and 34.8% were ≥60 years. Structural heart disease was present in 87.8%, predominantly involving the mitral valve. Blood cultures were positive in 57.1%, with Staphylococcus aureus as the leading pathogen (25%), whereas 42.9% were culture-negative. Echocardiographic evidence of IE was documented in 80.9%, and valve surgery was performed in 51.5%. In-hospital mortality was 36.6%. Independent predictors of death included age ≥60 years (OR 7.0), hypertension (OR 3.9), new valvular regurgitation (OR 6.3), thrombocytopenia ≤150×10³/mm³ (OR 3.5), total bilirubin ≥1.2 mg/dL (OR 15.4), and arterial lactate >1.6 mmol/L (OR 5.2). In this real-world cohort, IE was characterized by diagnostic limitations, a high proportion of culture-negative cases, and high in-hospital mortality. Readily available clinical and laboratory parameters showed prognostic value and may support early risk stratification in resource-limited settings.

23 April 2026 in Clinics
Verified
Journal Article
Open access
MMMariana Velho Menoia
Mariana Velho Menoia
GPGuilherme Barbosa Pinto
Guilherme Barbosa Pinto
EIErika Yukie Ishigaki
Erika Yukie Ishigaki
NDNicoly Caroline de Andrade Delmondes
Nicoly Caroline de Andrade Delmondes
DNDaniel Ayabe Ninomiya
Daniel Ayabe Ninomiya
MMMarcello Magri
Marcello Magri
To evaluate the impact of the COVID-19 pandemic on outpatient follow-up and clinical outcomes of People Living with HIV (PLHIV) at a specialized infectious diseases clinic in southeastern Brazil. A retrospective analysis was conducted using medical records and responses to a structured questionnaire from PLHIV followed between March 2020 and December 2021. Clinical and laboratory data (CD4 count, viral load, and antiretroviral therapy changes) were reviewed, and questionnaire responses were used to assess COVID-19 history, vaccination, and mental health symptoms. A total of 125 patients were included (mean age 38.6-years; 64.1% male). Prior to the pandemic, 80.3% had CD4 counts > 200 cells/µL and 82.1% had undetectable viral load, increasing to 89.7% and 84.6%, respectively, during the pandemic. Twenty-six patients (22.2%) changed their antiretroviral regimen, mainly due to switching to the nationally recommended first-line therapy. Among the 55 respondents to the questionnaire, 13 (24%) reported confirmed COVID-19 infection; of these, 2 (15.4%) required hospitalization. Overall, 53 (96.4%) reported having received the COVID-19 vaccination. Symptoms of depression and anxiety were reported by 27.7% and 45.4% of participants, respectively. Despite the logistic challenges associated with the COVID-19 pandemic, viral suppression, immunologic recovery, and retention in care remained stable in this selected cohort of patients with continuous follow-up, reflecting the resilience of the healthcare service and sustained treatment adherence.